🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Mexico / NCT06278571
Active, not recruiting Not applicable

Effect of Education With Mobile App on Metabolic Control in Patients With Type 2 Diabetes

NCT06278571 · tracked via the Priya Life Science Mexico tracker
Phase
Not applicable
Started
2023-01-30
Last updated
2025-04-24

Condition(s) studied

Female

Investigational drug(s) / intervention(s)

Educational intervention with App and web site educationEducational interventión with web site educationControl group with nutritional therapy

Educational intervention with App and web site education: This group will only receive intervention with access to the educational website from home, where they will review the different modules focused on diabetes care, nutrition and exercise. in addition to the usual medical care by your treating physician.

Educational interventión with web site education: This group will receive, in addition to nutritional therapy, diabetes education through an educational site, to learn more about the most important aspects of diabetes care. In addition to the usual medical care by your treating physician.

Control group with nutritional therapy: This group will receive only the usual medical care by your treating physician.

Study summary

The objective of this study is to compare the effect of education through a mobile application with medical and nutritional reinforcement on the metabolic control of Mexican patients with type 2 diabetes attending primary care clinics in Mexico.

The research question is: What is the effect of education through a mobile application with medical and nutritional reinforcement vs.

nutritional and medical reinforcement, versus an educational platform to influence the metabolic control of patients with type 2 diabetes? Multicenter clinical trial in six family medicine units of the Mexican Institute of Social Security. These selected units are: UMF 9, UMF 28, UMF 7, UMF 1, UMF 9 and UMF 10.

Patients with type 2 diabetes will be randomly assigned to the educational intervention through the educational site, (n=160 patients), two clinics will be assigned for the use of the mobile App and the educational site (n=160 patients), and two clinics will be part of the control group (n=160 patients).

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion criteria * Patients with type 2 diabetes. * Enrolled as beneficiaries of the Mexican Social Security Institute. * With HbA1 greater than 7% and less than 13%. * With and without pharmacological treatment for diabetes (hypoglycemic agents or insulin). * Who can read and write. * With ≤ 60 years of age7. * With ≤10 years of diabetes diagnosis. Exclusion criteria * chronic kidney disease with renal replacement therapy * blindness * lower limb amputation * cancer

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Instituto Mexicano Del Seguro Social Mexico City Mexico City

More Coordinación de Investigación en Salud, Mexico trials in Mexico

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06278571 on ClinicalTrials.gov ↗ ← All trials in Mexico